Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc. (MDMA.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDMA.CN · as of Jun 8, 2026
Key Statistics
Explore Pharmala Biotech Holdings Inc. Data
mdma.cn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mdma.cn competitorsMDMA.CN
BETR.CN
BLAB.CN
CHS.V
GLOW.CN
HEM.VStock Performance
Full HistoryAbout Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc. doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ing…
what is pharmala biotech holdings inc. · mdma.cn stock overview · pharmala biotech holdings inc. company profile · who is pharmala biotech holdings inc. ceo · mdma.cn CNQ · pharmala biotech holdings inc. headquarters · pharmala biotech holdings inc. business segments
About Stock Overview & Key Data
Pharmala Biotech Holdings Inc. (MDMA.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since Jan 11, 2022. As of the latest trading session, MDMA.CN stock price is $0.14, with a market capitalization of $15.8M. The stock has returned +23.81% over the past 12 months and +18.18% year-to-date.
In fiscal year 2025, Pharmala Biotech Holdings Inc. reported revenue of $605498.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pharmala Biotech Holdings Inc. (MDMA.CN) stock price is $0.14. The stock is traded on CNQ under the ticker symbol MDMA.CN. The 52-week range is $0.09 – $0.20.